Ausgabe 3/2012
Inhalt (11 Artikel)
Obesity: a new risk factor for cardiac syndrome X?
Priscilla Lamendola, Gaetano Antonio Lanza
Thiazolidinedione Drugs Promote Onset, Alter Characteristics, and Increase Mortality of Ischemic Ventricular Fibrillation in Pigs
Mohammad Sarraf, Li Lu, Shuyu Ye, Michael J. Reiter, Clifford R. Greyson, Gregory G. Schwartz
Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity
Gerald Maarman, Erna Marais, Amanda Lochner, Eugene F du Toit
H2 Mediates Cardioprotection Via Involvements of KATP Channels and Permeability Transition Pores of Mitochondria in Dogs
Akemi Yoshida, Hiroshi Asanuma, Hideyuki Sasaki, Shoji Sanada, Satoru Yamazaki, Yoshihiro Asano, Yoshiro Shinozaki, Hidezo Mori, Akito Shimouchi, Motoaki Sano, Masanori Asakura, Tetsuo Minamino, Seiji Takashima, Masaru Sugimachi, Naoki Mochizuki, Masafumi Kitakaze
Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate–Induced Cardioprotection
Sarin J. Somers, Miguel Frias, Lydia Lacerda, Lionel H. Opie, Sandrine Lecour
Obesity, Inflammation and Brachial Artery Flow-Mediated Dilatation: Therapeutic Targets in Patients with Microvascular Angina (Cardiac Syndrome X)
Peter Ong, Ramyya Sivanathan, Gabor Borgulya, Mukhtar Bizrah, Yassir Iqbal, Joycelyn Andoh, David Gaze, Juan Carlos Kaski
A Review of Time Courses and Predictors of Lipid Changes with Fenofibric Acid-Statin Combination
Theodosios D. Filippatos
Pleiotropic Effects of Dronedarone on Ischemia/Reperfusion Injury in Heart and Brain
Gerd Heusch, Rainer Schulz
Novel Oral Anticoagulants After Acute Coronary Syndromes
Newton B. Wiggins, Christopher B. Granger, John H. Alexander
Recombinant Human Interleukin-1 Receptor Antagonist Provides Cardioprotection During Myocardial Ischemia Reperfusion in the Mouse
Stefano Toldo, Aaron M. Schatz, Eleonora Mezzaroma, Raveen Chawla, Thomas W. Stallard, William C. Stallard, Arehzo Jahangiri, Benjamin W. Van Tassell, Antonio Abbate